According to Arrowhead Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 851.37.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 42.1 | 122.32% |
2023-12-31 | 18.9 | 62.49% |
2022-12-31 | 11.6 | -37.39% |
2021-12-31 | 18.6 | 7.22% |
2020-12-31 | 17.3 | 35.12% |
2019-12-31 | 12.8 | 91.47% |
2018-12-31 | 6.71 | 70.94% |
2017-12-31 | 3.92 | 231.67% |
2016-12-31 | 1.18 | -70.21% |
2015-12-31 | 3.97 | 43.26% |
2014-12-31 | 2.77 | -47.01% |
2013-12-31 | 5.23 | 18.8% |
2012-12-31 | 4.40 | 57.21% |
2011-12-31 | 2.80 | -68.24% |
2010-12-31 | 8.82 | 73.56% |
2009-12-31 | 5.08 | -35.68% |
2008-12-31 | 7.90 | 50.5% |
2007-12-31 | 5.25 | 16.85% |
2006-12-31 | 4.49 | -23.12% |
2005-12-31 | 5.84 | -7.34% |
2004-12-31 | 6.31 | 12481.19% |
2003-12-31 | 0.0501 | -352.71% |
2002-12-31 | -0.0198 |